🔗 Share this article

Given that America continues making sweeping changes to its vaccination guidelines, an unexpected name has surfaced somewhat surprisingly: Høeg, a Danish American physician and epidemiologist who initially gained attention by questioning Covid shots in the pandemic and has zeroed in on possible deaths after Covid immunization in her short position at the Food and Drug Administration.

Scheduled Shifts to Pediatric Immunization Program

Health officials had intended to unveil major revisions to the childhood immunization program earlier this month, synchronizing the US with Denmark’s vaccine program, it is understood – a substantial departure that would place the US out of alignment with many the world with no evidence for benefit. This reveal has been pushed back until the coming year.

Instead of the director of the vaccine center, Høeg is listed to present at the meeting. She was recently named acting director of the FDA’s Center for Drug Evaluation and Research (CDER), the fifth individual to lead the division this calendar year.

A Shift at the Agency

The acting appointment may indicate a strengthened alliance between the pharmaceutical and biologics divisions as Høeg and Prasad strengthen their influence at the regulatory agency – and it signals a increased emphasis upon rolling back already-approved vaccines at the FDA.

Dr. Høeg has repeatedly called for discontinuing some pediatric vaccine recommendations in the US to become more in line with Denmark, a society with nationalized medicine and a number of inhabitants approximately the size of Wisconsin’s.

In her initial comments, she has persisted in emphasizing on vaccines – traditionally the purview of Dr. Prasad, director of the FDA’s CBER – instead of medication approval.

Concerns Over Expertise

The appointee has little discernible track record in medication creation, oversight or management, which has been typical for former directors of the biologics center. She has worked at the FDA as a top consultant to the agency head and the vaccine center since March.

“It seems she lacks to have the necessary background” for leading the CDER, said a neurologist and psychiatrist. “She has not conducted a scientific study. She is not versed in leading a large organization. She is not an expert in drug approvals.”

Past heads of CBER would “grasp laws and regulations and the underlying principles of medication creation”, said Dr. Janet Woodcock. “Frankly, she has not acquired the kind of background that previous people who headed the center have had.”

The drug center has an vast range of responsibilities at the agency, Woodcock pointed out.

“Everybody just pays attention on the novel medication approvals, but the generic drug division clears thousands of generic drugs. There’s a biosimilars program, OTC medication office and more, and every single one must be looked after,” Woodcock noted. “The area you don’t keep your eye on, that is the part that I always told people is going to come back to haunt you.”

There is also, a substantial leadership component to the job, which manages over 5,000 personnel. “It’s a enormous leadership role, if you do it right,” Woodcock said.

Agency Reaction and Contentious Programs

Regarding concerns about Høeg’s fitness for the role and whether this appointment signifies increased cooperation among FDA leaders on immunizations, a press secretary responded that the “inquiries are based on inaccurate premises”.

“Her experience is consistent with the functions of her role,” the representative stated, citing the period Høeg spent guiding the agency head on “medication safety and regulatory science, including predictive safety algorithms and vaccine surveillance”.

As acting director, Høeg inherits the commissioner’s controversial expedited review system, a contentious one-day medication authorization process that allegedly troubled her predecessors. “By what process are these drugs being selected for this fast-track system? Who takes the choices?” Howard said. “There’s a lot of lack of transparency occurring at the regulatory body right now.”

Broadly speaking, he remarked, “the agency appears to be shifting towards laxer regulations of most medications, aside from vaccines.”

Established History on Vaccines

Concerning immunizations, Dr. Høeg has a more documented, if troubling, track record, Howard have noted. She released a study using non-validated volunteer-provided data to estimate the frequency of heart inflammation after COVID-19 vaccination. She counseled the state of Florida chief medical officer Dr. Joseph Ladapo, who allegedly have modified findings to suggest COVID-19 vaccines are riskier than they are.

Included in her “wish list” for the new government encompassed altering guidelines for recently developed shots and discontinuing “non-essential” vaccines, she remarked post-election on a online show. At the agency, Dr. Høeg has reportedly floated the idea of preventing teenage boys from receiving COVID-19 vaccines.

“She is an thorough dogmatist who begins with her beliefs and works backwards to accommodate the science in a very disingenuous, untruthful manner,” Howard argued.

Taking Control and a “Push for Payback”

Høeg joined other contrarians, {like|